Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging
This is not the latest version of this item. The latest version can be found here.

Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging

Thumbnail Image
Download
Name

nihms895179.pdf

Description
Accepted version
Size

1.36 MB

Format

Adobe PDF

Checksum (MD5)

6552e3ee0ae8faa5feeb874c2e504e1b

sword-2019-09-06T18:52:17.original.xml (130 B)
Original SWORD entry document
Author(s)
Fay, Francois
•
Hansen, Line
•
Hectors, Stefanie JCG
•
Sanchez-Gaytan, Brenda L
•
Zhao, Yiming
•
Tang, Jun
•
Munitz, Jazz
•
Alaarg, Amr
•
Braza, Mounia S
•
Gianella, Anita
more
Date Issued
2017
Journal
Bioconjugate Chemistry
Publisher
American Chemical Society (ACS)
Version
Author's final manuscript
Abstract
© 2017 American Chemical Society. Active targeting of nanoparticles through surface functionalization is a common strategy to enhance tumor delivery specificity. However, active targeting strategies tend to work against long polyethylene glycol's shielding effectiveness and associated favorable pharmacokinetics. To overcome these limitations, we developed a matrix metalloproteinase-2 sensitive surface-converting polyethylene glycol coating. This coating prevents nanoparticle-cell interaction in the bloodstream, but, once exposed to matrix metalloproteinase-2, i.e., when the nanoparticles accumulate within the tumor interstitium, the converting polyethylene glycol coating is cleaved, and targeting ligands become available for binding to tumor cells. In this study, we applied a comprehensive multimodal imaging strategy involving optical, nuclear, and magnetic resonance imaging methods to evaluate this coating approach in a breast tumor mouse model. The data obtained revealed that this surface-converting coating enhances the nanoparticle's blood half-life and tumor accumulation and ultimately results in improved tumor-cell targeting. Our results show that this enzyme-specific surface-converting coating ensures a high cell-targeting specificity without compromising favorable nanoparticle pharmacokinetics.
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
https://hdl.handle.net/1721.1/134578
DOI of Published Version
10.1021/ACS.BIOCONJCHEM.7B00086
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.